65,437 trials
Influenza Prophylaxis
Primary: Anti Influenza Hemagglutination Inhibition (HAI) Antibody Geometric Mean Titers (GMT) — 3.55; 3.49; 6.19; 6.13 Titers
Obesity · Inflammation
Primary: Proresolution Index — 0.71; 0.84 ratio — p=0.2780
Cardiac Allograft Vasculopathy
Primary: Number of Subjects With a Perfusion Defect — 5; 6 Participants
Anxiety · Depression
Primary: Reaction Time to Facial Affect Identification During Emotional Conflict — 802.15; 889.14; 848.79; 937.97 milliseconds — p=0.004
Fracture Fixation, Intramedullary · Surgical Wound Infection
Primary: Incidence of Surgical Site Infection (SSI) Relating to Intramedullary Nailing for Fixation of Diaphyseal Femoral and Tibial Fractures — 26; 195 Participants
Head and Neck Cancer · Larynx
Primary: Primary Site Complete Response Rate — 6; 4 Participants
Hypertension in Pregnancy
Primary: Number of Participants Whose Blood Pressure Was Assessed in the First Ten Days Following Discharge — 45; 95 Participants
Pregnancy Related
Primary: Breastfeeding Assessment — 121.2; 120.3 days
Type 1 Diabetes Mellitus
Primary: Change From Baseline in HbA1c to Month 6 — -0.399; -0.402 Percentage of HbA1c — p=0.965
Post-operative Pain · Gynecological Surgery · Acupuncture
Primary: Morphine Equivalent Usage While in the Hospital — 29.59; 30.82; 10.54; 11.74 mg
Colitis, Ulcerative
Primary: Number of Participants With Treatment-Emergent Adverse Events, Serious Adverse Events, and Who Withdrew Due to Adverse Events — 33; 3; 8; 1 Participants
Hip Fracture · Pressure Ulcer
Primary: Number of Participants With Pressure Sores — 8; 28 Participants
Dry Eye
Primary: Mean Change From Baseline in Tear Film Break-Up Time (TFBUT) at Day 35 — 0.999; 0.864 seconds — p=<0.0001
Obesity
Primary: Intra- and Post-operative Serum Concentrations — 17; 14; 9; 5 µg.mL-1
Critical Limb Ischemia
Primary: To Determine Platelet Inhibition Before and After Switching for Two Weeks From Clopidogrel to Ticagrelor in Patients With CLI. — 173; 140; 71; 63 P2Y12 reaction units…